Electroporation-mediated transfer of SOX trio genes (SOX-5, SOX-6, and SOX-9) to enhance the chondrogenesis of mesenchymal stem cells

Stem Cells and Development

Volumn 20, Issue 12, 2011, Pages 2103-2114

  Kim, Hye Joung ^a   Im, Gun Il ^a  

^a Dongguk University Ilsan Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; TRANSCRIPTION FACTOR SOX5; TRANSCRIPTION FACTOR SOX6; TRANSCRIPTION FACTOR SOX9; TRANSFORMING GROWTH FACTOR BETA1;

AGED; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CHONDROGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROPORATION; GENE EXPRESSION; GENE TRANSFER; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MESENCHYMAL STEM CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

AGED; APOPTOSIS; BIOLOGICAL MARKERS; CELL COUNT; CELL PROLIFERATION; CHONDROCYTES; CHONDROGENESIS; COLLAGEN; DNA; ELECTROPORATION; GENE EXPRESSION REGULATION; GLYCOSAMINOGLYCANS; GREEN FLUORESCENT PROTEINS; HUMANS; MESENCHYMAL STEM CELLS; PLASMIDS; REAL-TIME POLYMERASE CHAIN REACTION; SOX TRANSCRIPTION FACTORS; SOX9 TRANSCRIPTION FACTOR; SOXD TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 80055121358     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2010.0516     Document Type: Article

References (29)

1. Buckwalter JA and HJ Mankin1998). Articular cartilage: degeneration and osteoarthritis, repair, regeneration, and transplantation. Instr Course Lect 47:487-504.
2. Buckwalter JA, HJ Mankin and AJ Grodzinsky2005). Articular cartilage and osteoarthritis. Instr Course Lect 54:465-480.
3. Brittberg M, A Lindahl, A Nilsson, C Ohlsson, O Isaksson and L Peterson1994). Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 331:889-895.
4. Lefebvre V, C Peeters-Joris and G Vaes1990). Production of collagens, collagenase and collagenase inhibitor during the dedifferentiation of articular chondrocytes by serial subcultures. Biochim Biophys Acta 1051:266-275.
5. Caplan AI2005). Review: mesenchymal stem cells: cellbased reconstructive therapy in orthopedics. Tissue Eng 11:1198-1211.
6. Caplan AI1991). Mesenchymal stem cells. J Orthop Res 9:641-650.
7. Pittenger MF, AM Mackay, SC Beck, RK Jaiswal, R Douglas, JD Mosca, MA Moorman, DW Simonetti, S Craig and DR Marshakl1999). Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
8. Barry F, RE Boynton, B Liu and JM Murphy2001). Chondrogenic differentiation of mesenchymal stem cells from bone marrow: differentiation- dependent gene expression of matrix components. Exp Cell Res 268:189-200.
9. Caplan AI and VM Goldberg1999). Principles of tissue engineered regeneration of skeletal tissues. Clin Orthop Relat Res 367 Suppl:S12-S16.
10. De Bari C, F Dell'Accio, P Tylzanowski and FP Luyten2001). Multipotent mesenchymal stem cells from adulthuman synovial membrane. Arthritis Rheum 44:1928-1942.
11. Lefebvre V, W Huang, VR Harley, PN Goodfellow and B de Crombrugghe1997). SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene. Mol Cell Biol 17:2336-2346.
12. Lefebvre V, RR Behringer and B de Crombrugghe2001). L-Sox5, Sox6 and Sox9 control essential steps of the chondrocyte differentiation pathway. Osteoarthritis Cartilage 9 Suppl A:S69-S75.
13. Zhao Q, H Eberspaecher, V Lefebvre and B De Crombrugghe1997). Parallel expression of Sox9 and Col2a1 in cells undergoing chondrogenesis. Dev Dyn 209:377-386.
14. Smits P, P Li, J Mandel, Z Zhang, JM Deng, RR Behringer, B de Crombrugghe and V Lefebvre2001). The transcription factors L-Sox5 and Sox6 are essential for cartilage formation. Dev Cell 1:277-290.
15. Smits P, P Dy, S Mitra and V Lefebvre2004). Sox5 and Sox6 are needed to develop and maintain source, columnar, and hypertrophic chondrocytes in the cartilage growth plate. J Cell Biol 164:747-758.
16. Im GI, YW Shin and KB Lee2005). Do adipose tissuederived mesenchymal stem cells have the same osteogenic and chondrogenic potential as bone marrow-derived cells? Osteoarthritis Cartilage 13:845-853.
17. Im GI, NH Jung and SK Tae2006). Chondrogenic differentiation of mesenchymal stem cells isolated from patients in late adulthood: the optimal conditions of growth factors. Tissue Eng 12:527-536.
18. Gavrieli Y, Y Sherman and SA Ben-Sasson1992). Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119: 493-501.
19. Scholzen T and J Gerdes2000). The Ki-67 protein: from the known and the unknown. J Cell Physiol 182:311-322.
20. Karsenty G2001). Minireview: transcriptional control of osteoblast differentiation. Endocrinology 142:2731-2733.
21. Nakashima K, X Zhou, G Kunkel, Z Zhang, JM Deng, RR Behringer, et al2002). The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 11;108:17-29.
22. Muraglia A, R Cancedda and R Quarto2000). Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J Cell Sci 113:1161-1166.
23. Ikeda T, S Kamekura, A Mabuchi, I Kou, S Seki, T Takato, K Nakamura, H Kawaguchi, S Ikegawa and UI Chung I2004). The combination of SOX5, SOX6, and SOX9 (the SOX trio) provides signals sufficient for induction of permanent cartilage. Arthritis Rheum 50:3561-3573.
24. Cucchiarini M, T Thurn, A Weimer, D Kohn, EF Terwilliger and H Madry2007). Restoration of the extracellular matrix in human osteoarthritic articular cartilage by overexpression of the transcription factor SOX9. Arthritis Rheum 56: 158-167.
25. Tew SR, Y Li, P Pothacharoen, LM Tweats, RE Hawkins and TE Hardingham2005). Retroviral transduction with SOX9 enhances re-expression of the chondrocyte phenotype in passaged osteoarthritic human articular chondrocytes. Osteoarthritis Cartilage 13:80-89.
26. Sinn PL, SL Sauter and PB McCray, Jr2005). Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors-design, biosafety, and production. Gene Ther 12:1089-1098.
27. Bleiziffer O, E Eriksson, F Yao, RE Horch and U Kneser2007). Gene transfer strategies in tissue engineering. J Cell Mol Med 11:206-223.
28. Singh TR, MJ Garland, CM Cassidy, K Migalska, YK Demir, S Abdelghany, E Ryan, AD Woolfson and RF Donnelly2010). Microporation techniques for enhanced delivery of therapeutic agents. Recent Pat Drug Deliv Formul 4:1-17.
29. Wang YH, ML Ho, JK Chang, HC Chu, SC Lai and GJ Wang2009). Microporation is a valuable transfection method for gene expression in human adipose tissue-derived stem cells. Mol Ther 17:302-308.